Covered recipient · General Payments record
SAURABH VISHNUKUMAR PARASRAMKA
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2021–2024
$5,140.15
- Reported across 267 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,208.42 | 59 |
| Education | $16.40 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $131.26 | 7 |
| Daiichi Sankyo Inc. | $118.87 | 5 |
| Incyte Corporation | $105.88 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $88.54 | 4 |
| Genentech USA, Inc. | $80.92 | 4 |
| PFIZER INC. | $76.02 | 4 |
| Merck Sharp & Dohme Corporation | $66.80 | 3 |
| Acerta Pharma LLC | $56.19 | 3 |
| Genmab U.S., Inc. | $53.12 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $52.39 | 3 |
| ABBVIE INC. | $52.27 | 3 |
| E.R. Squibb & Sons, L.L.C. | $47.89 | 3 |
| Gilead Sciences, Inc. | $41.51 | 2 |
| Regeneron Healthcare Solutions, Inc. | $35.92 | 1 |
| Rigel Pharmaceuticals, Inc. | $30.07 | 1 |
| Tempus AI, Inc | $28.54 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $22.50 | 1 |
| JAZZ PHARMACEUTICALS INC. | $20.49 | 1 |
| Telix Pharmaceuticals | $19.05 | 1 |
| Karyopharm Therapeutics Inc. | $18.51 | 1 |
| GENZYME CORPORATION | $17.38 | 1 |
| Lilly USA, LLC | $17.16 | 1 |
| Celgene Corporation | $15.71 | 1 |
| BeiGene USA, Inc. | $14.15 | 1 |
| Coherus Biosciences Inc. | $13.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (60)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.